Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice

about

Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice

Item

http://www.wikidata.org/entity/Q57063313

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Expert opinion for use of faec ...... ase in daily clinical practice

@en

Expert opinion for use of faec ...... ase in daily clinical practice

@nl

type

Item

label

Expert opinion for use of faec ...... ase in daily clinical practice

@en

Expert opinion for use of faec ...... ase in daily clinical practice

@nl

prefLabel

Expert opinion for use of faec ...... ase in daily clinical practice

@en

Expert opinion for use of faec ...... ase in daily clinical practice

@nl

P1476

Expert opinion for use of faec ...... ase in daily clinical practice

@en

P2093

Anneline Cremer

http://www.w3.org/2001/XMLSchema#string

Catherine Reenaers

http://www.w3.org/2001/XMLSchema#string

Filip Baert

http://www.w3.org/2001/XMLSchema#string

Hilde Vanpoucke

http://www.w3.org/2001/XMLSchema#string

Pieter Hindryckx

http://www.w3.org/2001/XMLSchema#string

P2860

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

Epidemiology and natural history of inflammatory bowel diseases

Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

Predictability of the postoperative course of Crohn's disease.

Vedolizumab as induction and maintenance therapy for Crohn's disease.

Evaluation of Nine Consensus Indices in Delphi Foresight Research and Their Dependency on Delphi Survey Characteristics: A Simulation Study and Debate on Delphi Design and Interpretation

Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn's disease: a long-term prospective study.

P304

1117-1125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2050640618784046

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Bossuyt

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30288273

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

Aka

P932

6169045

http://www.w3.org/2001/XMLSchema#string